Does New Zealand have an innovation system for biotechnology?

Marsh, Dan

Does New Zealand have an innovation system for biotechnology?

dc.contributor.author	Marsh, Dan
dc.date.accessioned	2008-12-15T20:59:35Z
dc.date.available	2008-12-15T20:59:35Z
dc.date.issued	2002-05
dc.description.abstract	While there is a large and growing international literature on economic aspects of biotechnology innovation (e.g. work by Carlsson, McKelvey, Orsenigo, Zucker and Darby) these studies concentrate on the United States and Europe. The New Zealand biotechnology industry may be expected to develop along a different trajectory as a consequence of a markedly different set of initial and framework conditions. This paper presents the results of an ongoing study that aims to fill some of the gaps in our knowledge of innovation processes in New Zealand while using the international literature as a benchmark. The size and structure of modern biotech activity in New Zealand is described and compared to other OECD countries using biotech patent data and results from the New Zealand and Canadian biotechnology surveys. The paper then focuses on factors affecting innovation in biotechnology; framework conditions, government policy R&D funding and the role of networks and other linkages.	en_US
dc.format.mimetype	application/pdf
dc.identifier.citation	Marsh, D. (2002). Does New Zealand have an innovation system for biotechnology?. (Department of Economics Working Paper Series, Number 3/02). Hamilton, New Zealand: University of Waikato.	en_US
dc.identifier.uri	https://hdl.handle.net/10289/1656
dc.language.iso	en
dc.relation.ispartofseries	Department of Economics Working Paper Series
dc.subject	biotechnology	en_US
dc.subject	innovation system	en_US
dc.subject	survey data	en_US
dc.subject	New Zealand	en_US
dc.title	Does New Zealand have an innovation system for biotechnology?	en_US
dc.type	Working Paper	en_US
uow.relation.series	3/02